Repligen RGEN
NASDAQ RGEN
$181.70 +4.47 (+2.52%)
At close: Oct 2, 2026 · 4:00 PM EDT

Repligen (RGEN) Non Operating Interest Expenses (2011 - 2026)

Updated

Repligen's Non Operating Interest Expenses was $5.66 million in Q2 2026, up 5.8% from $5.35 million a year earlier and up 1.5% from the prior quarter.

Analysis

Repligen (RGEN) Non Operating Interest Expenses (2011 - 2026) Analysis & Trends

On a trailing twelve-month basis, Repligen's Non Operating Interest Expenses was $22.15 million through Jun 30, 2026, up 4.5% year-over-year; for FY2025, it came in at $21.51 million, up 3.8% from FY2024.

  • Non Operating Interest Expenses has now increased for three consecutive years, with a five-year compound annual growth rate of 14.8% (FY2020 to FY2025).
  • In earlier years, Non Operating Interest Expenses was $20.73 million in FY2024 (+728.2%), $2.5 million in FY2023 (+115.4%), $1.16 million in FY2022 (-89.7%) and $11.28 million in FY2021 (+4.7%).
  • The Q2 2026 figure marks the highest quarterly Non Operating Interest Expenses in data going back to Q2 2012.
  • Compared with a year earlier, Non Operating Interest Expenses has increased for seven straight quarters, with growth averaging 50.8% over the last seven quarters.
  • The best year-over-year quarter for Non Operating Interest Expenses over five years was Q4 2023 (growth of 372.6%); the worst was Q4 2022 (a decline of 90.6%).
  • Per Business Quant data, RGEN's Non Operating Interest Expenses in the three quarters before Q2 2026 was $5.58 million (Q1 2026), $5.5 million (Q4 2025) and $5.41 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 401.00 Mn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 351.00 Mn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 107.00 Mn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 186.00 Mn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 141.00 Mn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 96.00 Mn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn -
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 132.00 Mn
10 Repligen 10.85 Bn 7.74 Bn 110.04 Mn 5.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.66 Mn
Mar 31, 2026 5.58 Mn
Dec 31, 2025 5.50 Mn
Sep 30, 2025 5.41 Mn
Jun 30, 2025 5.35 Mn
Mar 31, 2025 5.25 Mn
Dec 31, 2024 5.46 Mn
Sep 30, 2024 5.12 Mn
Jun 30, 2024 5.12 Mn
Mar 31, 2024 5.03 Mn
Dec 31, 2023 1.28 Mn
Sep 30, 2023 408,000.00
Jun 30, 2023 411,000.00
Mar 31, 2023 408,000.00
Dec 31, 2022 270,000.00
Sep 30, 2022 329,000.00
Jun 30, 2022 271,000.00
Mar 31, 2022 292,000.00
Dec 31, 2021 2.88 Mn
Sep 30, 2021 2.86 Mn
API Access

Repligen Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=RGEN&period=max&api_key=YOUR_API_KEY